BioStem Technologies, Inc. - Form 4 Filing

This filing details transactions by Jodi Ungrodt, a director at BioStem Technologies, Inc. (BSEM). The report indicates Ungrodt holds 5,648 shares of Common Stock. Additionally, Ungrodt has been granted Restricted Stock Units (RSUs) which vest in two installments: May 27, 2026, and August 27, 2026. Each RSU corresponds to one share of the company's common stock. The RSUs have a conversion or exercise price noted by a footnote.